Human Papillomavirus (hpv) Warts Therapeutics
1. Veregen patent expiration
Treatment: Treatment of genital warts
VEREGEN IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10434059 | ANI PHARMS | Medicament for the treatment of viral skin and tumour diseases |
Nov, 2022
(3 years ago) | |
| US5795911 | ANI PHARMS | Composition for treating Condyloma acuminata |
Oct, 2020
(5 years ago) | |
| US5968973 | ANI PHARMS | Method for treating hyperplasia |
Apr, 2017
(8 years ago) | |
| US9770406 | ANI PHARMS | Medicament for the treatment of viral skin and tumour diseases |
Jul, 2025
(5 months ago) | |
| US7858662 | ANI PHARMS | Medicament for the treatment of viral skin and tumour diseases |
Oct, 2026
(8 months from now) | |
Drugs and Companies using SINECATECHINS ingredient
Market Authorisation Date: 31 October, 2006
Dosage: OINTMENT
More Information on Dosage
VEREGEN family patents
